MCS110 With BRAF/MEK Inhibition in Patients With Melanoma
Clinical trial NCT03455764 · COMPLETED
Trial details
- NCT number
- NCT03455764
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2023-09-05
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.